FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3018950211> ?p ?o ?g. }

• W3018950211 endingPage "5623" @default.
• W3018950211 startingPage "5585" @default.
• W3018950211 abstract "The BET family of proteins consists of BRD2, BRD3, BRD4, and BRDt. Each protein contains two distinct bromodomains (BD1 and BD2). BET family bromodomain inhibitors under clinical development for oncology bind to each of the eight bromodomains with similar affinities. We hypothesized that it may be possible to achieve an improved therapeutic index by selectively targeting subsets of the BET bromodomains. Both BD1 and BD2 are highly conserved across family members (>70% identity), whereas BD1 and BD2 from the same protein exhibit a larger degree of divergence (∼40% identity), suggesting selectivity between BD1 and BD2 of all family members would be more straightforward to achieve. Exploiting the Asp144/His437 and Ile146/Val439 sequence differences (BRD4 BD1/BD2 numbering) allowed the identification of compound 27 demonstrating greater than 100-fold selectivity for BRD4 BD2 over BRD4 BD1. Further optimization to improve BD2 selectivity and oral bioavailability resulted in the clinical development compound 46 (ABBV-744)." @default.
• W3018950211 created "2020-05-01" @default.
• W3018950211 creator A5003712444 @default.
• W3018950211 creator A5014237694 @default.
• W3018950211 creator A5017259712 @default.
• W3018950211 creator A5021063321 @default.
• W3018950211 creator A5021095828 @default.
• W3018950211 creator A5029810586 @default.
• W3018950211 creator A5033294241 @default.
• W3018950211 creator A5036792126 @default.
• W3018950211 creator A5038244916 @default.
• W3018950211 creator A5040295474 @default.
• W3018950211 creator A5040413688 @default.
• W3018950211 creator A5044757881 @default.
• W3018950211 creator A5044796135 @default.
• W3018950211 creator A5046289569 @default.
• W3018950211 creator A5051244627 @default.
• W3018950211 creator A5052371425 @default.
• W3018950211 creator A5063285496 @default.
• W3018950211 creator A5070247681 @default.
• W3018950211 creator A5074957787 @default.
• W3018950211 creator A5076720827 @default.
• W3018950211 creator A5078721849 @default.
• W3018950211 creator A5085149487 @default.
• W3018950211 creator A5087031558 @default.
• W3018950211 date "2020-04-23" @default.
• W3018950211 modified "2023-09-29" @default.
• W3018950211 title "Discovery of <i>N</i>-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain" @default.
• W3018950211 cites W1966227037 @default.
• W3018950211 cites W1968827652 @default.
• W3018950211 cites W1976654542 @default.
• W3018950211 cites W1990174038 @default.
• W3018950211 cites W1998805995 @default.
• W3018950211 cites W2017789254 @default.
• W3018950211 cites W2024469844 @default.
• W3018950211 cites W2060484997 @default.
• W3018950211 cites W2070033262 @default.
• W3018950211 cites W2091368230 @default.
• W3018950211 cites W2123647733 @default.
• W3018950211 cites W2129265683 @default.
• W3018950211 cites W2227664819 @default.
• W3018950211 cites W2261819980 @default.
• W3018950211 cites W2270241120 @default.
• W3018950211 cites W2291572778 @default.
• W3018950211 cites W2331559401 @default.
• W3018950211 cites W2378228402 @default.
• W3018950211 cites W2399229449 @default.
• W3018950211 cites W2417522152 @default.
• W3018950211 cites W2587935821 @default.
• W3018950211 cites W2592276570 @default.
• W3018950211 cites W2597078857 @default.
• W3018950211 cites W2605100179 @default.
• W3018950211 cites W2606852909 @default.
• W3018950211 cites W2625872407 @default.
• W3018950211 cites W2740027129 @default.
• W3018950211 cites W2760757128 @default.
• W3018950211 cites W2765889348 @default.
• W3018950211 cites W2769887441 @default.
• W3018950211 cites W2770647912 @default.
• W3018950211 cites W2784402914 @default.
• W3018950211 cites W2786719846 @default.
• W3018950211 cites W2795518453 @default.
• W3018950211 cites W2797801723 @default.
• W3018950211 cites W2887927543 @default.
• W3018950211 cites W2892851404 @default.
• W3018950211 cites W2924630110 @default.
• W3018950211 cites W2953873379 @default.
• W3018950211 cites W2969333205 @default.
• W3018950211 cites W3001038414 @default.
• W3018950211 cites W886495568 @default.
• W3018950211 doi "https://doi.org/10.1021/acs.jmedchem.0c00628" @default.
• W3018950211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32324999" @default.
• W3018950211 hasPublicationYear "2020" @default.
• W3018950211 type Work @default.
• W3018950211 sameAs 3018950211 @default.
• W3018950211 citedByCount "79" @default.
• W3018950211 countsByYear W30189502112020 @default.
• W3018950211 countsByYear W30189502112021 @default.
• W3018950211 countsByYear W30189502112022 @default.
• W3018950211 countsByYear W30189502112023 @default.
• W3018950211 crossrefType "journal-article" @default.
• W3018950211 hasAuthorship W3018950211A5003712444 @default.
• W3018950211 hasAuthorship W3018950211A5014237694 @default.
• W3018950211 hasAuthorship W3018950211A5017259712 @default.
• W3018950211 hasAuthorship W3018950211A5021063321 @default.
• W3018950211 hasAuthorship W3018950211A5021095828 @default.
• W3018950211 hasAuthorship W3018950211A5029810586 @default.
• W3018950211 hasAuthorship W3018950211A5033294241 @default.
• W3018950211 hasAuthorship W3018950211A5036792126 @default.
• W3018950211 hasAuthorship W3018950211A5038244916 @default.
• W3018950211 hasAuthorship W3018950211A5040295474 @default.
• W3018950211 hasAuthorship W3018950211A5040413688 @default.
• W3018950211 hasAuthorship W3018950211A5044757881 @default.
• W3018950211 hasAuthorship W3018950211A5044796135 @default.
• W3018950211 hasAuthorship W3018950211A5046289569 @default.
• W3018950211 hasAuthorship W3018950211A5051244627 @default.
• W3018950211 hasAuthorship W3018950211A5052371425 @default.
• W3018950211 hasAuthorship W3018950211A5063285496 @default.

• next